首页> 外文期刊>Analytical methods >Efficient purification of low molecular weight nitrogen polar compounds from the skin of Bufo bufo gargarizans Cantor by reversed-phase high performance liquid chromatography with a polar-copolymerized C18 stationary phase
【24h】

Efficient purification of low molecular weight nitrogen polar compounds from the skin of Bufo bufo gargarizans Cantor by reversed-phase high performance liquid chromatography with a polar-copolymerized C18 stationary phase

机译:极性共聚C18固定相反相高效液相色谱法从蟾蜍体内高效纯化低分子量氮极性化合物

获取原文
获取原文并翻译 | 示例
       

摘要

Cinobufacini (Huachansu) injections have been widely used for the treatment of various cancers in clinical applications in China. As an aqueous extract of the skin of Bufo bufo gargarizans Cantor (toad skin), cinobufacini contains many polar compounds; however the chemical profile of these polar compounds is still unclear, which increases the risk of pharmacological safety. There are very few studies on the separation and purification of polar components from toad skin, especially in the preparative scale. In this study, a unique method based on a homemade polar-modified C18 stationary phase was developed and successfully applied to separate polar compounds from toad skin. Compared with previous purification systems based on the C18 stationary phase, the poor retention problem of polar compounds was well resolved through the use of the polar-modified C18 column and good resolutions were also achieved. Seven compounds were purified and five of them (uracil, hypoxanthine, 3-hydroxy-4H-pyrazolo[4,5-d]pyridazin-7(1H)-one, thymine and bufothionine) were identified by MS, ~1H NMR and ~(13)C NMR. In addition, 3-hydroxy-4H-pyrazolo[4,5-d]pyridazin-7(1H)-one was identified as a new compound and hypoxanthine was found from the skin of Bufo bufo gargarizans Cantor for the first time. These results indicate that this method shows promise for the separation of polar compounds in toad skin.
机译:奇诺法西尼(华蟾素)注射液在中国的临床应用中已广泛用于治疗各种癌症。作为蟾蜍(蟾蜍皮肤)的皮肤的水提取物,cinobufacini包含许多极性化合物。然而,这些极性化合物的化学性质仍不清楚,这增加了药理安全性的风险。关于从蟾蜍皮中分离和纯化极性成分的研究很少,特别是在制备规模上。在这项研究中,开发了一种基于自制极性修饰的C18固定相的独特方法,并将其成功地用于从蟾蜍皮中分离极性化合物。与以前的基于C18固定相的纯化系统相比,通过使用极性改性的C18色谱柱可以很好地解决极性化合物保留效果差的问题,并且还可以实现良好的分离度。纯化了七个化合物,其中五个化合物(尿嘧啶,次黄嘌呤,3-羟基-4H-吡唑并[4,5-d]哒嗪-7(1H)-一,胸腺嘧啶和布非硫宁)通过MS,〜1H NMR和〜 (13)C NMR。此外,3-羟基-4H-吡唑并[4,5-d]哒嗪-7(1H)-被鉴定为一种新化合物,首次从中华蟾蜍的皮肤中发现了次黄嘌呤。这些结果表明该方法显示了蟾蜍皮肤中极性化合物分离的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号